Cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis.
Eli Johnson
Abstract
Eli Johnson
Abstract
Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1991.9.6.1092 Journal of Clinical Oncology - published online before print September 22, 2016 PMID: 1709684 Cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis. E JohnsonxE JohnsonSearch for articles by this author https://doi.org/10.1200/JCO.1991.9.6.1092 First Page PDF © 1991 by American Society of Clinical Oncology
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1991.9.6.1092 Journal of Clinical Oncology - published online before print September 22, 2016 PMID: 1709684 Cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis. E JohnsonxE JohnsonSearch for articles by this author https://doi.org/10.1200/JCO.1991.9.6.1092 First Page PDF © 1991 by American Society of Clinical Oncology
Key concepts: Vinblastine, Bleomycin, Cisplatin, Etoposide, Medicine, Germ cell tumors, Oncology, Cancer research